Alcon introduces presbyopia-correcting IOL Clareon PanOptix Pro in the US

Image credit: AdobeStock/AfricaStudio

Alcon has now introduced its new Clareon PanOptix Pro intraocular lens (IOL) for patients with cataracts in the US. The presbyopia-correcting IOL will be Alcon’s first to be available in the US in the company’s single-use Clareon AutonoMe preloaded delivery system. PanOptix Pro has been introduced to select practices across the US, with broad commercial availability planned for in May, according to a news release.

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob Scott, vice president of Intraocular Devices, R&D at Alcon, in the release. “Our team looked at hundreds of design options, ultimately landing on a targeted diffractive refinement that helped us recover 50% of light lost to scatter, and reposition it to a beneficial focal point for PanOptix Pro. This allowed for specific enhancements while maintaining the features that have driven the success of PanOptix—the world’s most implanted trifocal IOL.”

The IOL utilizes proprietary ENLIGHTEN NXT Optical technology, which delivers the highest reported light utilization of any trifocal IOL, along with the lowest light scatter. The lens also allows more uninterrupted light distribution from distance to near, along with a 16% increase in optical image contrast between distance and intermediate. PanOptix Pro contributes to the clinically-proven low visual disturbance profile, high spectacle independence, and high patient satisfaction of PanOptix, according to the release.

“PanOptix has been a game-changer in my practice, allowing me to reliably offer many of my patients complete freedom from glasses after cataract surgery,” said Kerry Solomon, MD, medical director at Carolina Eyecare Physicians, LLC, in the release. “I was excited to learn that Alcon evolved this leading technology for more light utilization and less light scatter. My early patient results with PanOptix Pro support that this advancement builds on the well-established performance of PanOptix.”

Alcon is also planning to make PanOptix Pro available for use with the Clareon Monarch IV delivery system beginning in 2026. The lens offers powers ranging from +6.0 through +30.0 diopters in 0.5 diopter increments, +31.0 through +34.0 diopters in 1.0 increments, and a +2.17 diopter intermediate and +3.25 diopter near add power. PanOptix Pro will also be available with blue light and ultraviolet filtering.

Reference:

1. Alcon expands leadership in IOL innovation with Clareon PanOptix Pro, delivering best-in-class light utilization and less light scatter. News release. Businesswire. April 2, 2025. Accessed April 3, 2025. https://www.businesswire.com/news/home/20250401378074/en/Alcon-Expands-Leadership-in-IOL-Innovation-with-Clareon-PanOptix-Pro-Delivering-Best-in-Class-Light-Utilization-and-Less-Light-Scatter